CLIN
Rebekah Brown, MD (she/her/hers)
Vanderbilt University Medical Center
Patrick Flume, MD
Medical University of South Carolina
The experience of people living with cystic fibrosis in the US has changed over the past several years, influenced by improvements in therapies, approval of CFTR modulators, and the SARS-CoV-2 pandemic. With recent improvements in outcomes for people with cystic fibrosis, as well as advancements in therapies and remote technology to support healthcare, it is time to re-evaluate the cystic fibrosis model of care to attend to the various needs of people with cystic fibrosis. This symposium will discuss the support for changes in the model of care and cystic fibrosis team, outline interim guidance for care, and discuss future steps for evaluating potential modifications in cystic fibrosis care in the US.
Speaker: Rebekah F. Brown, MD (she/her/hers) – Vanderbilt University Medical Center
Speaker: Charlotte T. Close, MS, CGC (she/her/hers) – Columbia University Irving Medical Center
Speaker: Danielle M. Goetz, MD (she/her/hers) – UBMD Pediatric Pulmonology/Oishei Children's Hospital
Speaker: Patrick A. Flume, MD – Medical University of South Carolina